We recently developed a simple technique for the generation of relatively large (31-codon) insertion mutations in cloned genes. To test whether the analysis of such mutations could provide insight into structurefunction relationships in proteins, we examined a set of insertion mutants of the Escherichia coli lac repressor (LacI). Representatives of several LacI mutant classes were recovered, including mutants which exhibit fully active, inducer-insensitive, or weak dominant-negative phenotypes. The various properties of the recovered mutants agree with previous biophysical, biochemical, and genetic data for the protein. In particular, the results support the prior designation of mutationally tolerant spacer regions of LacI as well as proposed differences in dimerization interactions among regions of the protein core domain. These findings suggest that the analysis of 31-codon insertion mutations may provide a simple approach for characterizing structurefunction relationships in proteins for which high-resolution structures are not available.
A powerful combination of biochemistry, genetics, biophysics, and molecular biology has provided fundamental insights into the complex relationships which exist among protein sequence, structure, and function. Such a combination of approaches has produced a detailed view of the way in which the Escherichia coli lac repressor (LacI) structure gives rise to the multiple functions of this homotetrameric three-domain protein (17, 23, 25, 31, 39, 48, 51) . The first of these is the Nterminal headpiece domain of LacI. Interactions between headpiece domains of the tetramer allow LacI to bind specifically to lac operator DNA sequences and function as a transcriptional repressor of the lac operon (19, 21, 22, 25, 41, 42, 43) . At the C-terminal end of the headpiece domain is a linker segment which joins the headpiece of each monomer to the allosteric core domain of the protein (18) . This linker segment is disordered in the absence of target DNA but becomes ␣-helical when the DNA headpiece domain binds DNA (25) .
The large core domain of the protein is composed of N and C subdomains formed from noncontiguous segments of the amino acid chain as predicted by comparison to the effector domains of periplasmic binding proteins and PurR (37, 39, 46, 48) . This core domain functions mainly in protein dimerization and in binding to lac inducers such as allolactose and isopropyl-␤-D-thiogalactopyranoside (IPTG) (16, 42, 43) . IPTG binding alters the interface between the core N subdomains within the dimer, and this structural change is likely transmitted through the hinge helices to the DNA-binding headpiece domains (25, 49) . A resulting reduction in the overall affinity of the LacI DNA-binding domains for operator DNA sequences effects an increase in lac transcription (5, 21, 33) . Another linker segment joins the core domain to the third domain of LacI, a C-terminal ␣-helix which is largely responsible for the formation of functional LacI tetramers (2, 3, 6, 14, 16, 40) .
LacI mutants disrupting each of its activities have been characterized. Many mutations occurring within the first 60 codons of lacI result in a dominant-negative phenotype (LacI Ϫd ) since the mutant proteins retain oligomerization and inducer binding activity but are deficient in DNA binding (1, 6, 20, 34) . Certain mutations in the core domain alter responses to the inducer (LacI s , LacI r ) (11, 23, 36, 50, 54) . Finally, mutations disrupting oligomerization have helped to identify dimer and tetramer interfaces in the core domain and C-terminal ␣-helix domain (2, 9, 10, 14, 15, 36, 47) .
Previous genetic studies examining structure-function relationships in the lac repressor and other proteins have exploited a variety of techniques, including gene fusions, alanine-scanning mutagenesis, combinatorial cassette mutagenesis, and more comprehensive amino acid substitution mutageneses (7, 31, 36, 44, 45, 53) . Since the lac repressor is relatively well characterized, we have used it here as a model to test the value for structure-function studies of a new, transposon-based method for generating 31-codon insertion mutations (29) .
MATERIALS AND METHODS
Bacterial strains and plasmids. The following E. coli K-12 strains were used in this study: CC191 [F 128 lacI q ⌬(lacZ)m15/⌬(ara-leu)7697 ⌬(lac)X74 phoA20 galE galK thi rpsE rpoB argE(Am) recA1 (24) . The starting plasmids used for this study were all derived from pTrc99A (4), which carries lacI q . The pTrc99A derivatives originally contained either the malF, malG, or malK gene cloned into the plasmid polylinker. Following the isolation of the insertion mutations in lacI, these plasmids were restricted with NcoI and HindIII at the polylinker to completely remove the mal gene and thus simplify characterization of the lacI mutations. The resulting plasmids were designated placI-4535, e.g., to correspond with the respective mutant lacI allele (e.g., lacI-4535::i31). In the text and in Tables 2 through 5 , each mutant LacI protein expressed from this set of plasmids is denoted by a number corresponding to the amino acid after which the 31-codon insertion occurs (e.g., placI-4535 expresses LacI-7) (see Table 1 ).
Media and cell growth. The media used have been described previously (29, 32) . The following medium supplements were used at the concentrations indicated: kanamycin, 30 g/ml; ampicillin, 100 g/ml; chloramphenicol, 30 g/ml; 5-bromo-4-chloro-3-indolyl␤-D-galactopyranoside (X-Gal), 40 g/ml; sucrose, 5% (wt/vol).
DNA manipulations. Standard DNA preparations and manipulations were used (28) . Insertion site DNA was sequenced by the dideoxynucleotide termination method by use of Sequenase (United States Biochemical) with doublestranded plasmid DNA templates and the appropriate oligonucleotide primer (26) .
TnlacZ/in-mediated insertion mutagenesis. Our protocol was based on the two-step mutagenesis procedure of Manoil and Bailey (29; see also reference 26).
Cells containing the lacI plasmid were infected with a replication-deficient lambda phage carrying the TnlacZ/in transposon, divided into independent pools, plated at 30°C, and grown for 36 to 40 h on L agar plus chloramphenicol, ampicillin, and sucrose to select for the transposition of the ISlacZ/in element. Plasmid DNA was isolated by alkaline lysis and then transformed into CC191 cells. Cells with plasmids expressing LacI fused to ␤-galactosidase from the ISlacZ/in element were identified as blue colonies on plates containing X-Gal, chloramphenicol, and ampicillin. After restriction mapping of candidate plasmids to approximate the insert location, appropriate candidates were sequenced to determine the precise insert location. Plasmids containing the ISlacZ/in element in lacI were then restricted with BamHI to remove the majority of the insertion sequences and religated to produce the 93-bp insert (Fig. 1) .
␤-Galactosidase assays. Assays were carried out as described by Kleina and Miller (23) with a few modifications: from fresh plates, mutant strains (CSH140 or BN29 background) were grown overnight at 32°C in minimal glycerol broth, diluted into fresh minimal glycerol broth, and grown at 37°C for approximately 105 min (optical density at 600 nm, between 0.3 and 0.6). Miller units (32) were used to calculate ␤-galactosidase activity levels. All assays were performed at least three times. For induction assays, 10 Ϫ2 , 10 Ϫ3 , or 10 Ϫ4 M IPTG was added to each culture for 30 min prior to assaying ␤-galactosidase levels.
Western blot (immunoblot) analysis. Western blot analysis was carried out as described by Traxler and Beckwith (52) . CSH140 cells were transformed by all 18 mutant lacI plasmids and pTrc99A as a negative control, since wild-type LacI does not contain the 31-codon insert. Protein levels were normalized by use of the Bio-Rad protein assay, and protein samples were heated at 65°C for 20 min prior to gel loading. A sodium dodecyl sulfate-12.5% polyacrylamide gel was used to separate proteins, which were then transferred to a 0.2-m-pore-size nitrocellulose filter. LacI mutant proteins were detected after incubation with a 1:1,000 dilution of polyclonal antipeptide antibody directed against the 31-codon insert (29) .
LacI dominance testing assay. Selected LacI mutants were tested for potential dominant-negative phenotypes by use of the ␤-galactosidase assay as described above. Plasmids expressing LacI-7, LacI-11, and LacI-53 were tested in strains DHB4 and DHB24; LacI-261 and wild-type LacI (pTrc99A) were both included as negative controls. Results were expressed in ␤-galactosidase units (32) as the average of three or more assays.
RESULTS
Randomness of lacI mutagenesis. We wanted to characterize the effects of TnlacZ/in-mediated insertions of 31 amino acids (aa) (29) on a well characterized protein, the lac repressor. We selected for transposition events of the TnlacZ/in transposon involving only the IS50 L element (ISlacZ/in), which contains both a cat (chloramphenicol resistance) gene and a truncated lacZ gene. Approximately 75,000 colonies containing ISlacZ/in inserts were then screened to identify potential insertion mutants of LacI. Thirty candidates were selected for sequencing based on ␤-galactosidase activity of the protein resulting from fusion of LacI and LacZ and on restriction mapping data. From these candidates, 18 different in-frame lacI insertion mutants were obtained (Table 1) . Five insertion mutants were isolated twice, and insertions at one position, represented by LacI-258, were recovered independently at least five times (the number designation of the LacI mutant refers to the amino acid of LacI after which the 31-residue insertion occurs) ( Table  1 ). Our insertion mutagenesis of the lacI gene involved no screen or selection for the activity of the LacI protein, thus minimizing potential bias towards the isolation of any particular class of mutant. Additionally, the 18 different insertions were distributed throughout the lacI gene and fell into all three of the previously described protein domains. The lack of major hot spots, with the possible exception of the site corresponding to mutant LacI-258, suggests that TnlacZ/in displayed no strong insertional bias for particular lacI sequences.
LacI insertion mutant classifications. Miller and colleagues classified an extensive collection of LacI mutants by their ability to repress expression of lacZ (23, 31) . We have categorized the in vivo activity of our set of LacI insertion mutant proteins by use of a similar classification scheme, although our mutants were expressed from a high-copy-number plasmid instead of from an Flac factor. In our analysis, the ␤-galactosidase (LacZ) level of the lacI lacZ ϩ strain CSH140 represents the baseline. The ␤-galactosidase levels of CSH140 transformed with plasmid pTrc99A expressing LacI ϩ and with pTrc99A-derived plasmids expressing the different LacI insertion mutants were all compared to the baseline to determine the activity classification of each mutant.
The 18 LacI insertion mutants fell into five classes based on their relative abilities to repress lacZ expression ( Table 2) . Three mutants, LacI-152, LacI-317, and LacI-338, possessed increased repressor activity in excess of 2,000-fold that of the LacI Ϫ baseline and were classified as highly active (ϩϩ). The most active of these, LacI-317 (26,400-fold increase over the LacI Ϫ baseline), had repression levels similar to those of the LacI ϩ control (33,400-fold). Mutants LacI-94 and LacI-340 each retained increased repressor activity in excess of 200-fold compared to the LacI Ϫ baseline and were considered to be active (ϩ). Mutants LacI-67 and LacI-72 exhibited partial repressor activity (between 20-fold and 200-fold greater than LacI Ϫ levels) and constituted a third mutant class (ϩ/Ϫ). Mutant LacI-142 also retained significant levels of repressor activity, about 13-fold greater than the LacI Ϫ baseline, and was classified as weakly active (Ϫ/ϩ). The 10 other LacI mutants each retained less than twofold-greater repression activity above LacI Ϫ levels and were considered to be inactive (Ϫ). Oehler and coworkers (40) reported that a mutant lac repressor protein capable of forming only dimers retained greater than 50% of wild-type LacI activity when assayed at high intracellular levels. At low protein levels, however, the same LacI mutant retained less than 2% of wild-type repressor activity. Based on these observations, we decided to assay the repression activities of mutants LacI-338 and LacI-340 at low intracellular concentrations by using a pcnB strain which reduces plasmid copy number approximately 10-fold (27) . The insertions in mutants LacI-338 and LacI-340 both map near the C-terminal ␣-helix tetramerization domain of LacI; LacI-338 also retained greater than 50% of wild-type activity under high-plasmid-copy number conditions (Table 2) . Under lowplasmid-copy number conditions, LacI-338 behaved similarly to the tetramerization-defective mutant in the Oehler et al. study (40) , retaining only about 2% of wild-type LacI repression levels. Under these same conditions, LacI-340 retained slightly less than 2% of wild-type activity or about twofoldgreater activity than that of the LacI Ϫ control (Table 2) . Western blot analysis. We determined the relative protein expression levels of the 18 LacI insertion mutants by Western blot analysis (Fig. 2) . Two prominent bands were observed in most samples, i.e., the LacI protein band migrating at about 49 kDa and a background band migrating at about 33.3 kDa. All but two of the inactive mutants (LacI-11 and LacI-197) accumulated protein to detectable levels, indicating that the loss of repressor activity was not due merely to an absence of protein in the cells. Inactive mutant LacI-53, whose insertion localizes to the linker helix between the DNA-binding domain and the core domain of LacI, produced two protein bands whose sizes are consistent with full-length and N-terminally truncated LacI (the latter likely resulting from proteolysis at the mutated linker region). Earlier reports have indicated that this linker is particularly susceptible to proteolysis (18, 42) . b The amino acid of the LacI sequence directly preceding each 31-aa insertion site is given. c Nucleotides shown in italic type represent the wild-type lacI sequence, whereas nucleotides shown in boldface type represent the TnlacZ/in-derived insertion sequence (see also Fig. 1 ). Shown below each codon is the corresponding amino acid.
Different mobilities among several of the mutant LacI proteins may reflect variations in the amount of residual structure present in the mutant proteins during sodium dodecyl sulfatepolyacrylamide gel electrophoresis. Such mobility differences have also been observed among similar 31-residue insertion mutants of MalK and MalG (26, 37a) . The mobility variations of the mutant proteins are not attributable to transposonmediated rearrangements in lacI since restriction digest analysis confirmed the expected size and location of each lacI insertion (data not shown).
Inducer effects. Several of the active insertion mutants have insertion junctions in regions of LacI previously identified as important for proper inducer response. Mutant LacI-94 maps to a region (residues 95 to 97) which is believed to be responsible for transmitting the allosteric signal from the N-core subdomain to the DNA-binding head domain upon inducer binding (25, 51) (Fig. 3) . Mutants LacI-67 and LacI-72 map to another region (residues 63 to 84) near the inducer binding site in which multiple LacI s (or inducer-insensitive) mutants have been recovered (23, 25, 51) (Fig. 3) .
We assayed the repressor activities of the potential inducerinsensitive mutants LacI-67, LacI-72, and LacI-94 in the presence and absence of the inducer IPTG. Whereas the strain expressing mutant LacI-94 allowed a greater-than-100-fold increase in ␤-galactosidase levels when induced with 10 Ϫ3 M IPTG, insertion mutant LacI-72 was unresponsive to three different concentrations of IPTG, as demonstrated by a relatively constant induction value near 1.00 (Table 3) . LacI-67 also possessed an altered phenotype, as no increase in ␤-galactosidase levels was observed upon induction with three different IPTG concentrations; instead, a small but reproducible decrease in ␤-galactosidase expression occurred under all induction conditions tested (Table 3) . When the induction period was extended to 105 min for 10 Ϫ3 M IPTG, the induction value for LacI-67 decreased further to 0.384, whereas the LacI ϩ and LacI Ϫ controls had induction values of 642 and 0.961, respectively. All other active insertion mutants responded positively to induction with 10 Ϫ3 M IPTG for 30 min, as ␤-galactosidase units increased by a factor of 5-fold (for LacI-142) to about 350-fold (for LacI-317).
Dominance analysis. The inactive mutants LacI-7, LacI-11, and LacI-53 all map to the N-terminal headpiece domain of LacI. When tested at a high copy number for dominant-negative effects in a lacI q background, LacI-7 and LacI-11 had almost no effect whereas LacI-53 was found to exhibit a weak dominant-negative phenotype (LacI Ϫwd ; about a 10-fold increase in ␤-galactosidase expression compared to that of DHB4/pTrc99A) ( Table 4) . No dominant effect was evident, however, when LacI-53 was assayed in an isogenic pcnB strain (DHB24) in which the lacI plasmid copy number was reduced roughly 10-fold (27) .
DISCUSSION
A previous mutagenesis strategy involving relatively large insertions (average net insertion of 16 to 17 residues) has been used successfully to study the E. coli integral outer membrane protein LamB (12, 13, 38) . We used a simple new genetic approach to randomly generate 18 in-frame insertions of 31 residues in the lac repressor protein and analyzed the resulting mutant phenotypes. We reasoned that this characterization could be used to correlate genetic, biochemical, and structural data for the protein. Active and inactive mutants of the protein were recovered and characterized for their abilities to fold into a stable protein, repress lac expression, oligomerize, and bind inducer. We obtained representatives of several previously characterized mutant classes, including LacI Ϫd (dominant-negative) and LacI s (inducer-insensitive) mutants. In addition, we assigned our LacI mutant proteins to five different classes based on repression activity phenotype (summarized in Table  5 ). Below, we discuss several of the most interesting correlations that can be made between these LacI mutants and the recent biochemical, genetic, and crystal structure analyses (summarized in references 17, 23, 25, 31, 39, and 51). (Fig. 2) . Symbols and abbreviations: Ϫ, no detectable protein; ϩϩϩ, most prominent protein band; NA, not applicable; NT, not tested. Relative protein levels were not seen for wild-type LacI since the 31-codon insertion antibody was used for protein detection.
c Repression activity was calculated by dividing the ␤-galactosidase units (32) expressed from the CSH140 (or BN29) strain alone by the ␤-galactosidase units expressed by each mutant strain. Values obtained from multiple independent trials were then averaged to arrive at the final value for each mutant LacI protein.
␤-Galactosidase activity for CSH140 expressing LacI
ϩ from pTrc99A ranged from 0.070 to 0.456 U, and ␤-galactosidase activity for CSH140 alone ranged from 4,600 to 8,230 u.
d Activity classifications were based on repression levels (see Results for explanation of each activity class). NA, not applicable in a low-copy-number background since mutant activity classes were assigned based on repression levels in a high-plasmid-copy-number background.
Insertion mutant LacI-53 has its 31-residue insert located in the hinge helix of the DNA-binding (headpiece) domain which links the headpiece to the core domain of LacI. The weak dominant-negative effect of LacI-53 at high intracellular concentrations agrees with earlier mapping of LacI Ϫd mutants which places the mutations within the first 60 aa of the protein (1, 6, 20, 34) . The lack of dominance by this mutant at low intracellular concentrations may reflect partial folding or oligomerization interference of the core domain, thus favoring oligomerization among wild-type monomers.
Mutants LacI-67, LacI-72, and LacI-94 have insert junctions mapping to a region of the N subdomain of the LacI core implicated in both dimer formation and inducer binding (17, 25, 51) (Fig. 3) . The 31-residue inserts in these three mutant proteins evidently interfere with oligomerization only partially, since each mutant retained significant levels of repression activity, especially LacI-94. In addition, mutants LacI-67 and LacI-72 possessed altered phenotypes in the presence of inducer. The insertion mutation of LacI-72 is positioned at the lip of the inducer-binding region of the LacI core domain and may directly interfere with this binding process by disrupting a hydrophobic contact normally mediated by Leu-73 (Table 1 ) (17) . The repression capacity of LacI-67 not only was maintained upon induction with IPTG but also increased slightly. This aberrant behavior may be used to classify the mutant as inducer-insensitive (LacI s ) or even as a weak LacI r mutant (reverse-curve) (11, 23 ; reviewed in reference 33).
The observations (i) that all three of these mutants possess significant repressor activity, (ii) that LacI-72 and LacI-67 display altered inducer binding phenotypes, and (iii) that inactive mutants LacI-258, LacI-261, and LacI-281 all map to the dimerization interface of the core C subdomain (see below) agree with the modified Venus's-flytrap model (30) suggested by Suckow et al. (51) . This model proposes that specific dimer- (17) . The darkened residue side chains on the monomer to the right represent the amino acid directly preceding each insertion event and are labeled as such with the single-letter amino acid designation (e.g., A67 represents the insertion location of mutant LacI-67; see Table 1 for sequential context). Boldface underlined labels indicate active repressor mutants, whereas lightface labels without underlining indicate inactive mutants. Dashed lines indicate that the mutants were active in high intracellular concentrations but only very weakly active in low intracellular concentrations. ization of the LacI monomers is mediated mostly by C-core subdomain sequences independent of inducer binding, whereas N-core subdomains are involved in structural rearrangements primarily during induction, similar to that seen for PurR (49) .
An extensive series of amino acid substitutions through residue 329 of LacI and a more directed alanine replacement mutagenesis of the protein identified six stretches of mutationally tolerant amino acids, each 5 to 8 residues in length (31) . X-ray crystallography data position four of these tolerant regions at or near the surface of the N-core subdomain and two at relatively surface-exposed regions in the C-core subdomain of LacI (17, 25) . These regions are thought to serve as spacers which may connect more conserved hydrophobic residues important for protein folding and oligomerization (31, 51) . Active 31-residue insertion mutants LacI-142 (in the 140-to 144-aa region), LacI-152 (in the 151-to 158-aa region), and LacI-317 (in the 311-to 318-aa region) each map to spacer regions in the N-terminal core subdomain (Fig. 3) . Our results suggest that such surface-exposed spacer regions may be identified, in at least some cases, by their ability to accommodate large insertions.
Inactive mutants LacI-258, LacI-261, and LacI-281 all have insert junctions at relatively surface-exposed regions of the monomer. These three insertions, however, are contained in a region which is particularly intolerant of amino acid substitutions (31) and which has been implicated in dimer formation (specifically, residues 250 to 260 and 275 to 285) (9, 15, 25, 47, 51) (Fig. 3) . The insertion junctions of two other inactive LacI mutants, LacI-197 and LacI-297, both interrupt relatively surface-exposed ␣-helices of the core domain. In each case, the inserted sequence begins with a proline residue (Table 1) which likely prevents the completion of the helical structure by ensuing residues of the insertion. In the case of LacI-197, the resulting mutant protein was destabilized to the extent that no protein was detectable on a Western blot (Fig. 2) .
The insertion junction of LacI-338 lies in a linker region between the C-core subdomain and the C-terminal tetramerization ␣-helix of LacI (Fig. 3) . The insertion junction of mutant LacI-340 is C-terminal to that of LacI-338 by only two residues and directly precedes a series of leucine heptad repeats which are critical for LacI tetramerization (2, 3, 14) . Both mutants displayed significant repression activity in high intracellular concentrations, especially LacI-338. When assayed for activity in low intracellular concentrations, however, each mutant retained only about 2% of wild-type repression levels and only twofold to threefold-higher activity than the LacI Ϫ background. This dramatic decrease in repression activity agrees with earlier studies on tetramerization-defective mutants (40) and suggests that both LacI-338 and LacI-340 are severely impaired in their ability to form tetramers, resulting in a cellular population of low-activity dimers. LacI tetramerization in these mutants may be hampered by instability or misalignment of the C-terminal ␣-helix; the slight but reproducible difference in the repression activities of LacI-338 and LacI-340 perhaps relates to the respective proximities of their insertion junctions to the ␣-helix.
Use of insertion mutagenesis in analyzing protein structure and function. Transposon-mediated insertion mutagenesis has demonstrated several key features which make it an attractive method for protein analysis. This mutagenesis has provided a unique in vivo view of the contributions of different protein regions to stability, oligomerization, and function for a wellcharacterized protein and thus presents an alternative to other genetic techniques for complementing structural data. This approach has independently verified several important structural and functional aspects of the well-characterized lac repressor and should be useful for examining similar aspects of poorly characterized proteins and proteins not amenable to structural analysis by other methods. As a tool, it can highlight protein regions where more precise mutagenic analyses may be used to refine key elements of protein structure and function. COOH terminus tetramerization domain a Symbols: ϩϩ, repression activity over 2,000-fold above baseline levels (see Table 2 and Results); ϩ, 200-to 2,000-fold increase; ϩ/Ϫ, 20-to 200-fold increase; Ϫ/ϩ, 2-to 20-fold increase; Ϫ, less than 2-fold increase. Superscript s indicates an inducer-resistant phenotype, superscript wd indicates a weak dominant effect, and superscript wr indicates weak reverse-curve phenotype.
b HTH, helix-turn-helix. Numbers in parentheses refer to relevant stretches of amino acids; positional information was gathered from references 17, 25, 31, 39, and 51.
c LacI-338 and LacI-340 are both classified as active at high intracellular concentrations, although they are only very weakly active at low intracellular concentrations (see Discussion).
